Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of...

FDA Drug Recall #D-0355-2024 — Class II — February 2, 2024

Recall Summary

Recall Number D-0355-2024
Classification Class II — Moderate risk
Date Initiated February 2, 2024
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Bausch Health Companies, Inc.
Location Bridgewater, NJ
Product Type Drugs
Quantity 3,600 cartons

Product Description

Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.

Reason for Recall

Subpotent Drug: Out of specification for assay

Distribution Pattern

Nationwide

Lot / Code Information

Lot #0013R; Exp. 01/2026

Other Recalls from Bausch Health Companies, Inc.

Recall # Classification Product Date
D-0638-2021 Class III Mephyton (Phytonadione) 5 mg tablets, 100-count... Jun 8, 2021
D-0639-2021 Class III Phytonadione Tablets, 5 mg, 30-count ablets, Rx... Jun 8, 2021
D-0244-2021 Class III Phytonadione Tablets 5mg, 30-count bottle, Rx O... Jan 7, 2021
D-0243-2021 Class III Mephyton (phytonadione) Tablets 5mg, 100-count ... Jan 7, 2021
D-0054-2021 Class II Hydrocortisone butyrate Cream, 0.1%, 15-gram tu... Jul 13, 2020

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.